Sigma Planning Corp Buys Shares of 9,880 Aspen Aerogels, Inc. (NYSE:ASPN)

Sigma Planning Corp bought a new position in shares of Aspen Aerogels, Inc. (NYSE:ASPN) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 9,880 shares of the construction company’s stock, valued at approximately $274,000.

Other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. grew its position in Aspen Aerogels by 5.1% during the 1st quarter. Vanguard Group Inc. now owns 3,619,702 shares of the construction company’s stock worth $63,707,000 after acquiring an additional 175,906 shares during the last quarter. Hood River Capital Management LLC grew its holdings in shares of Aspen Aerogels by 12.2% during the first quarter. Hood River Capital Management LLC now owns 3,300,443 shares of the construction company’s stock worth $58,088,000 after purchasing an additional 357,895 shares during the last quarter. Driehaus Capital Management LLC grew its holdings in shares of Aspen Aerogels by 130.4% during the second quarter. Driehaus Capital Management LLC now owns 2,156,789 shares of the construction company’s stock worth $51,439,000 after purchasing an additional 1,220,724 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in Aspen Aerogels by 21.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,374,631 shares of the construction company’s stock valued at $32,790,000 after buying an additional 240,921 shares during the last quarter. Finally, American Century Companies Inc. raised its holdings in Aspen Aerogels by 562.3% in the 2nd quarter. American Century Companies Inc. now owns 770,729 shares of the construction company’s stock valued at $18,382,000 after buying an additional 654,350 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

ASPN has been the topic of several analyst reports. Benchmark reissued a “buy” rating and issued a $14.00 price objective on shares of Aspen Aerogels in a research note on Thursday, August 8th. Piper Sandler cut their target price on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. HC Wainwright reissued a “buy” rating and issued a $30.00 price target on shares of Aspen Aerogels in a research note on Wednesday, October 16th. Roth Mkm reduced their target price on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a report on Friday, November 8th. Finally, Barclays lowered their price target on shares of Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a report on Tuesday, November 12th. One investment analyst has rated the stock with a sell rating, nine have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Aspen Aerogels has a consensus rating of “Moderate Buy” and a consensus target price of $28.70.

Aspen Aerogels Stock Performance

NYSE:ASPN opened at $14.28 on Friday. The firm has a market capitalization of $1.17 billion, a P/E ratio of 1,427.93 and a beta of 2.21. Aspen Aerogels, Inc. has a twelve month low of $9.89 and a twelve month high of $33.15. The company has a fifty day moving average of $22.04 and a 200-day moving average of $24.59. The company has a quick ratio of 2.82, a current ratio of 2.93 and a debt-to-equity ratio of 0.27.

Insider Buying and Selling at Aspen Aerogels

In related news, CFO Ricardo C. Rodriguez sold 32,465 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the transaction, the chief financial officer now directly owns 20,790 shares in the company, valued at $626,610.60. This trade represents a 60.96 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Donald R. Young sold 63,355 shares of Aspen Aerogels stock in a transaction on Monday, September 30th. The shares were sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the sale, the chief executive officer now directly owns 483,640 shares of the company’s stock, valued at approximately $14,523,709.20. The trade was a 11.58 % decrease in their position. The disclosure for this sale can be found here. Insiders own 4.30% of the company’s stock.

Aspen Aerogels Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.